215 related articles for article (PubMed ID: 16772838)
1. Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour.
Pariente A; Etcharry F; Cales V; Laborde Y; Ferrari S; Biour M
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):785-7. PubMed ID: 16772838
[TBL] [Abstract][Full Text] [Related]
2. An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.
Aliberti S; Grignani G; Allione P; Fizzotti M; Galatola G; Pisacane A; Aglietta M
Am J Clin Oncol; 2009 Dec; 32(6):640-1. PubMed ID: 19955903
[No Abstract] [Full Text] [Related]
3. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.
Tonyali O; Coskun U; Yildiz R; Karakan T; Demirci U; Akyurek N; Benekli M; Buyukberber S
Med Oncol; 2010 Sep; 27(3):768-73. PubMed ID: 19662540
[TBL] [Abstract][Full Text] [Related]
4. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors.
Yachoui R
Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788
[TBL] [Abstract][Full Text] [Related]
5. [Imatinib-induced toxic hepatitis: description of two cases and review of the literature].
Fuster F; Medina L; Vallansot R; Granell M; Bruguera M
Gastroenterol Hepatol; 2007 Nov; 30(9):525-30. PubMed ID: 17980129
[TBL] [Abstract][Full Text] [Related]
6. Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage.
Loong HH; Yeo W
Hong Kong Med J; 2008 Dec; 14(6):495-8. PubMed ID: 19060352
[TBL] [Abstract][Full Text] [Related]
7. Transient respiratory failure possibly associated to imatinib.
Lengerke C; Brümmendorf T; Herrlinger U; Horger M; Kanz L; Hartmann JT
Invest New Drugs; 2005 Mar; 23(2):137-8. PubMed ID: 15744589
[No Abstract] [Full Text] [Related]
8. Histological features of acute hepatitis after imatinib mesylate treatment.
James C; Trouette H; Marit G; Cony-Makhoul P; Mahon FX
Leukemia; 2003 May; 17(5):978-9. PubMed ID: 12750713
[No Abstract] [Full Text] [Related]
9. Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient.
Demirci U; Coskun U; Erdem O; Ozturk B; Bilge Yilmaz I; Benekli M; Buyukberber S
J Oncol Pharm Pract; 2011 Sep; 17(3):285-7. PubMed ID: 20551113
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
Schindler CG; Armbrust T; Gunawan B; Langer C; Füzesi L; Ramadori G
Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
[TBL] [Abstract][Full Text] [Related]
11. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
Kong JH; Yoo SH; Lee KE; Nam SH; Kwon JM; Lee SM; Chang HJ; Choi MY; Cho MS; Mun YC; Nam E; Lee SN; Seong CM
Acta Haematol; 2007; 118(4):205-8. PubMed ID: 18030002
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
[TBL] [Abstract][Full Text] [Related]
13. Imatinib-induced bone edema: case report and review of literature.
dos Santos LV; Lima JP; Abdalla KC; Bragagnoli AC; Santos FA; dos Anjos Jácome A; Porto FE
J Natl Compr Canc Netw; 2013 Oct; 11(10):1187-91. PubMed ID: 24142819
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumor (GIST) and imatinib.
Kubota T
Int J Clin Oncol; 2006 Jun; 11(3):184-9. PubMed ID: 16850124
[TBL] [Abstract][Full Text] [Related]
15. Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics.
de Mestier P; des Guetz G
World J Surg; 2005 Mar; 29(3):357-61; discussion 362. PubMed ID: 15706444
[TBL] [Abstract][Full Text] [Related]
16. Imatinib-induced anasarca without heart failure: capillary leakage?
Sendur MA; Aksoy S; Civelek B; Zengin N
J BUON; 2012; 17(1):188-9. PubMed ID: 22517720
[No Abstract] [Full Text] [Related]
17. Lymphomatoid granulomatosis in a patient previously diagnosed with a gastrointestinal stromal tumour and treated with imatinib.
Salmons N; Gregg RJ; Pallalau A; Woolhouse I; Geh I; Tanière P
J Clin Pathol; 2007 Feb; 60(2):199-201. PubMed ID: 17264244
[No Abstract] [Full Text] [Related]
18. Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec.
Ganjoo KN; Demetri GD; Jacobs C; Patel S
Leuk Lymphoma; 2009 Nov; 50(11):1882-4. PubMed ID: 19883316
[No Abstract] [Full Text] [Related]
19. [Survival following liver transplant due to imatinib-induced acute liver failure: a case study].
García-Valdés M; Miras López M; Garrido Corro B; De La Rubia Nieto A
Farm Hosp; 2012; 36(1):50-1. PubMed ID: 21514865
[No Abstract] [Full Text] [Related]
20. Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate.
Ferraresi V; Catricalà C; Ciccarese M; Ferrari A; Zeuli M; Cognetti F
Anticancer Res; 2006; 26(6C):4771-4. PubMed ID: 17214339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
